OPA-15406

DRUG7 trials

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc., Otsuka Pharmaceutical Co., Ltd.

Conditions

Atopic DermatitisAtopic Dermatitis (AD)

Phase 1

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

CompletedNCT01702181

Otsuka Pharmaceutical Development & Commercialization, Inc.Atopic Dermatitis

Start: 2012-08-31End: 2013-12-31Updated: 2014-01-17

Phase 2

A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

CompletedNCT02068352

Otsuka Pharmaceutical Development & Commercialization, Inc.Atopic Dermatitis

Start: 2014-06-20End: 2015-02-03Updated: 2021-11-23

Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

CompletedNCT02914548

Otsuka Pharmaceutical Co., Ltd.Atopic Dermatitis

Start: 2016-09-30End: 2017-06-30Updated: 2020-07-23

Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

CompletedNCT03018691

Otsuka Pharmaceutical Co., Ltd.Atopic Dermatitis

Start: 2017-01-31End: 2017-06-30Updated: 2020-07-23

Phase 3

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

CompletedNCT05372653

Otsuka Pharmaceutical Co., Ltd.Atopic Dermatitis (AD)

Start: 2022-05-23End: 2023-11-29Updated: 2025-03-30

A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis

Not yet recruitingNCT07173478

Otsuka Pharmaceutical Co., Ltd.Atopic Dermatitis (AD)

Start: 2025-10-31End: 2026-12-31Target: 156Updated: 2025-09-15

A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis

Not yet recruitingNCT07184645

Otsuka Pharmaceutical Co., Ltd.Atopic Dermatitis (AD)

Start: 2025-09-30End: 2027-02-28Target: 198Updated: 2025-09-22

Related Papers

A Phase 3, Long-Term, Open-Label Study of Difamilast Ointment to Evaluate Efficacy and Safety in Japanese Infants with Atopic Dermatitis.

2025-10-31

An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis

Dermatology and Therapy2024-07-292 citations